title: [Blood antigens and specific anti-core and anti-envelope antibodies as markers of the course of HIV infection].
abstract: The antigenemia and the patterns of antibodies to core protein (p24) and envelope glycoproteins (gp41, gp120) have been investigated in 81 patients with Human Immunodeficiency Virus (HIV) infection followed prospectively for 24 months. HIV antigen was detectable in 23 (28.4%) patients at entry to the study (13/13 with AIDS and 10/23 with ARC) and in 33 (40.7%) at the end (25/28 with AIDS, 5/12 with ARC e 3/14 with LAS). Anti-p24 were positive in 51 (63.0%) patients at the entry (26/30 symptomless, 13/15 with LAS e 12/23 with ARC) and in 41 (50.6%) at the end of the study (23/27 symptomless, 9/14 with LAS, 7/12 with ARC e 2/28 with AIDS). All patients were positive for anti-gp41 and showed no significant changes in the antibody titers during the two years of follow-up; by contrast, anti-gp120 was undetectable in most patients (26/28) with AIDS. Clinical progression in a high proportion of patients was associated with the appearance of HIV antigen, with the decline of anti-p24 titers and with no antibody reactivity to gp120 glycoprotein.
authors.affiliation: Istituto di Malattie Infettive, Università La Sapienza, Roma.
authors.forename: F
authors.initials: F
authors.lastname: Sorice
authors.forename: V
authors.initials: V
authors.lastname: Vullo
authors.forename: A
authors.initials: A
authors.lastname: Cirelli
authors.forename: S
authors.initials: S
authors.lastname: Catania
authors.forename: C M
authors.initials: CM
authors.lastname: Mastroianni
authors.forename: C
authors.initials: C
authors.lastname: Contini
authors.forename: S
authors.initials: S
authors.lastname: Delia
mesh_terms: D000386:AIDS-Related Complex / Q000276:immunology; D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology; D015683:Gene Products, gag / Q000097:blood* / Q000276:immunology; D006678:HIV / Q000276:immunology*; D015483:HIV Antibodies / Q000097:blood*; D015488:HIV Antigens / Q000097:blood* / Q000276:immunology; D016655:HIV Core Protein p24; D015699:HIV Envelope Protein gp120 / Q000276:immunology*; D015700:HIV Envelope Protein gp41 / Q000276:immunology*; D015658:HIV Infections / Q000276:immunology* / Q000473:pathology; D006801:Humans; D011446:Prospective Studies; D013997:Time Factors; D014758:Viral Core Proteins / Q000097:blood* / Q000276:immunology; D014766:Viremia / Q000276:immunology
chemical_list: D015683:Gene Products, gag; D015483:HIV Antibodies; D015488:HIV Antigens; D016655:HIV Core Protein p24; D015699:HIV Envelope Protein gp120; D015700:HIV Envelope Protein gp41; D014758:Viral Core Proteins
vernacular_title: Antigenemia ed anticorpi specifici anti-core ed anti-envelope quali markers di evoluzione dell'infezione da HIV.